CYP2C19 and transient ischemic attack: In conclusion, ticagrelor/aspirin therapy was associated with greater platelet inhibition and more rapid onset in platelet inhibition compared with clopidogrel/aspirin therapy both in carriers and non-carriers of CYP2C19 LOF alleles with acute minor stroke or TIA.